key: cord-0936160-7shmlx84 authors: Caldaria, Antonio; Conforti, Claudio; Di Meo, Nicola; Dianzani, Caterina; Jafferany, Mohammad; Lotti, Torello; Zalaudek, Iris; Giuffrida, Roberta title: COVID‐19 and SARS: Differences and similarities date: 2020-04-30 journal: Dermatol Ther DOI: 10.1111/dth.13395 sha: 6c26454322af5003feb3bf96dc1fa48fcfb85fd8 doc_id: 936160 cord_uid: 7shmlx84 nan summarized in Table 1 . Genomic characterization has shown that SARS-CoV-2 share almost 80% of the genome with SARS-CoV but it contains additional gene regions (10b, 13, 14). 5 COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic Evaluation and Treatment Coronavirus (COVID-19) 2020 Learning from history: coronavirus outbreaks in the past Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan COVID-19) outbreak situation The reproductive number of COVID-19 is higher compared to SARS coronavirus Systematic comparison of two animal-tohuman transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV The COVID-19 epidemic